Assistant Director, Biodesign Faculty Fellowship, Stanford Byers Center for Biodesign
Founding Partner, 4i Ventures
President, Kalyan Oaks Advisors

Partha Ray is a healthcare executive, investor and advisor with 20+ years of deal & operating experience at leading global organizations. He has launched 6 FDA-regulated products worldwide and closed venture and strategic transactions which benefit over 9M patients and generate over $20B/yr in revenues today.

Partha works and invests in the intersection DeepTech and MedTech, i.e. robust technology-enabled businesses which aim to deliver proven clinical value. He engages with emerging health companies as expert board member, advisor and/or business executive (e.g. CBO). Partha's academic interests lie in the area of corporate innovation, with a particular focus on leveraging design thinking and interdisciplinary experience sets to enable actual need-based innovation in complex, global organizations. He's Faculty at a post-doc program at Stanford Biodesign and has helped select, mentor and graduate 36 Stanford Faculty to-date.

Global Product & Commercial Experience:
Partha has led global launches of 6 MedTech products and led a $500M/yr commercial business during 9 years in global marketing leadership roles at Medtronic (Diabetes) and Johnson & Johnson (Ethicon). He launched the world's first real-time continuous glucose monitoring (CGM) products, a category that is now serving over 4M users and generating $10B in revenue .

Deal experience:
Partha has diverse transactions experience including 8 equity investments, 2 M&As, 5 partnerships, and a JV deal gained over 10+ years in corporate business development, corporate venture capital, private venture capital, and angel investing. He has worked on major MedTech industry deals including a robotics surgery joint venture (Verb Surgical) between J&J (Ethicon) and Alphabet (Verily), the acquisition of Neuwave Medical at J&J (Ethicon), and the structuring of Dexcom Ventures.

Partha hold a BS in Electrical Engineering with honors from Northwestern University, an MBA from the UCLA Anderson School of Management, and was an Innovation Fellow at Stanford Biodesign.